Dedika is a platform where you learn by doing: whether it's creating a business proposal, becoming a nail technician, or using a new tool, for example. No matter your goal, the best content on the topic already exists. But it's often in another language, expensive, scattered around, lacks practice activities, or comes in courses that are too long for busy people. That's why Dedika has its own method: we find this material wherever it is, organize what makes sense for your goal, review it with experts who are available to answer your questions, and create practical exercises so you can learn by doing. You are the most important part of your journey and no one knows it better than you: choose the content and course length, decide if you'll study online or offline, and pick your preferred format. It can be video, text, audio, or a summary. Your way, only with what matters to you. Here, every moment you dedicate counts more and gets you to what matters faster.

Our courses include a summary at the end of each chapter, which you can download as a PDF and print.

Over 2 million learners across the globe

Available in more than 180 countries

Certificate valid in your country

Home Page

...

Psychotropic Drugs Course

All courses

Health and Medicine

Psychiatry

Psychotropic Drugs Course

For all levels

Psychotropic Drugs Course

Name: Psychotropic Drugs Course
Price: 8400 KES

Master the full spectrum of psychotropic pharmacology, from foundational neuroscience to complex clinical applications. This course equips mental health and medical professionals with the knowledge to prescribe, monitor, and optimise psychiatric medications confidently. Covering antidepressants, antipsychotics, mood stabilisers, anxiolytics, stimulants, and emerging therapies, it bridges pharmacological theory with real-world practice.

Dedika for businesses

What you will learn:

You will build an understanding of how psychotropic drugs work at the receptor level and how that knowledge translates into evidence-based clinical decisions. The course covers drug classes including antidepressants, antipsychotics, mood stabilisers, anxiolytics, and stimulants, along with their mechanisms, side effects, and monitoring requirements. You will learn to manage treatment-resistant cases, navigate drug interactions, and apply pharmacogenomics to individualise therapy. Special attention is given to vulnerable populations such as children, older adults, and pregnant patients. You will also explore emerging agents like esketamine and psychedelic-assisted therapies, regulatory and ethical frameworks, and strategies to improve patient adherence and communication.

How you study practically Psychotropic Drugs Course

How you practise Psychotropic Drugs Course

For companies looking to train their teams

With Dedika for businesses, the course includes exercises and examples tailored to your own business and the way your company needs.

Click here

Course content

8 Chapters • 40 LessonsDuration between 4 and 360 hours (you decide)

Chapter 1See details

Foundations of Psychopharmacology

Lesson 1 • Neurotransmitter Systems Overview
Covers the major neurotransmitter systems targeted by psychotropic drugs. Provides the biological foundation for understanding all subsequent drug mechanisms.
Lesson 2 • Pharmacodynamics and Drug Response
Examines dose-response relationships and therapeutic windows for psychotropic agents. Grounds students in predicting and interpreting clinical outcomes.
Lesson 3 • Receptor Pharmacology Essentials
Explains agonism, antagonism, and allosteric modulation at neuroreceptors. Links receptor binding concepts to clinical drug effects.
Lesson 4 • Drug Classification Systems
Introduces the major categories of psychotropic drugs and their clinical indications. Provides a taxonomy students will use throughout the entire course.
Lesson 5 • Pharmacokinetics of Psychotropic Drugs
Teaches absorption, distribution, metabolism, and excretion specific to CNS agents. Connects kinetic principles to dosing decisions and drug interactions.

Chapter 2See details

Antidepressants: Mechanisms and Use

Lesson 1 • Antidepressant Treatment Optimisation
Addresses augmentation strategies, switching protocols, and treatment-resistant depression. Integrates pharmacological decision-making with patient response monitoring.
Lesson 2 • Monoamine Hypothesis and Depression
Explains the neurobiological basis of depression and how antidepressants address it. Sets the theoretical framework for all antidepressant drug classes.
Lesson 3 • SSRIs and SNRIs in Practice
Covers selective serotonin and serotonin-norepinephrine reuptake inhibitors in clinical detail. Addresses onset, efficacy, and common adverse effects.
Lesson 4 • Atypical Antidepressants
Reviews bupropion, mirtazapine, and other agents with unique mechanisms. Highlights niche indications and differentiated side-effect profiles.
Lesson 5 • Tricyclics and MAOIs
Examines older antidepressant classes with distinct mechanisms and risk profiles. Prepares students to manage patients on legacy or treatment-resistant regimens.

Chapter 3See details

Antipsychotics: First and Second Generation

Lesson 1 • Antipsychotic Selection and Monitoring
Integrates clinical factors for individualised antipsychotic choice and ongoing safety monitoring. Builds systematic decision-making skills for complex psychotic disorder management.
Lesson 2 • Second-Generation Antipsychotics
Examines atypical antipsychotics with serotonin-dopamine antagonism and broader receptor profiles. Addresses metabolic risks and advantages over first-generation agents.
Lesson 3 • First-Generation Antipsychotics
Covers typical antipsychotics, their potency spectrum, and neurological side effects. Prepares students to recognise and manage extrapyramidal symptoms.
Lesson 4 • Dopamine Hypothesis of Psychosis
Explains the mesolimbic and mesocortical dopamine dysregulation underlying psychotic disorders. Provides the mechanistic rationale for antipsychotic drug design.
Lesson 5 • Long-Acting Injectable Formulations
Teaches the pharmacokinetics and clinical use of depot antipsychotics. Addresses adherence benefits and transition protocols from oral formulations.

Chapter 4See details

Mood Stabilisers and Bipolar Mood Disorder

Lesson 1 • Atypical Antipsychotics in Bipolar Mood Disorder
Reviews evidence for atypical antipsychotics in acute mania and bipolar depression. Connects antipsychotic pharmacology from Chapter 3 to bipolar-specific applications.
Lesson 2 • Bipolar Mood Disorder Pharmacotherapy Overview
Introduces the spectrum of bipolar mood disorder and the rationale for mood-stabilising agents. Frames treatment goals across manic, depressive, and maintenance phases.
Lesson 3 • Anticonvulsants as Mood Stabilisers
Examines valproate, lamotrigine, and carbamazepine in bipolar pharmacotherapy. Highlights differential efficacy across mood phases and teratogenic risks.
Lesson 4 • Lithium: Mechanisms and Management
Covers lithium's unique mechanism, narrow therapeutic index, and monitoring requirements. Prepares students for safe lithium initiation and long-term management.
Lesson 5 • Long-Term Bipolar Maintenance Strategies
Addresses relapse prevention, medication adherence, and monitoring in chronic bipolar management. Develops skills for individualised long-term treatment planning.

Chapter 5See details

Anxiolytics and Sedative-Hypnotics

Lesson 1 • Antidepressants for Anxiety Disorders
Applies antidepressant pharmacology from Chapter 2 to anxiety disorder treatment. Covers SSRIs, SNRIs, and TCAs as first-line and second-line anxiolytic options.
Lesson 2 • Z-Drugs and Melatonin Receptor Agents
Reviews non-benzodiazepine hypnotics and melatonin agonists for insomnia treatment. Addresses abuse potential differences and appropriate prescribing contexts.
Lesson 3 • Non-Benzodiazepine Anxiolytics
Examines buspirone, hydroxyzine, and beta-blockers as alternatives for anxiety management. Highlights mechanisms, onset differences, and appropriate patient selection.
Lesson 4 • Neurobiology of Anxiety and Sleep
Explains GABA, glutamate, and HPA axis dysregulation underlying anxiety and insomnia. Provides the biological rationale for anxiolytic and hypnotic drug targets.
Lesson 5 • Benzodiazepines: Benefits and Risks
Covers benzodiazepine pharmacology, clinical indications, and dependence liability. Prepares students to use benzodiazepines judiciously and manage withdrawal.

Chapter 6See details

Stimulants and ADHD Pharmacotherapy

Lesson 1 • Cardiovascular and Growth Monitoring
Addresses stimulant effects on heart rate, blood pressure, and paediatric growth. Builds systematic monitoring skills essential for safe long-term stimulant use.
Lesson 2 • Amphetamines and Methylphenidate
Covers the two major stimulant classes, their mechanisms, and formulation differences. Addresses efficacy, onset, and duration across immediate- and extended-release products.
Lesson 3 • Stimulant Misuse and Diversion Prevention
Addresses the abuse potential of stimulants and strategies to minimise diversion risk. Prepares students to balance therapeutic access with responsible prescribing practices.
Lesson 4 • Non-Stimulant ADHD Medications
Examines atomoxetine, guanfacine, and clonidine as stimulant alternatives. Highlights indications for non-stimulant use and their distinct onset and efficacy profiles.
Lesson 5 • Neurobiology of ADHD
Explains prefrontal cortex dopamine and norepinephrine deficits underlying ADHD symptoms. Provides the mechanistic basis for stimulant and non-stimulant treatment targets.

Chapter 7See details

Substance Use Disorders and Pharmacotherapy

Lesson 1 • Stimulant and Cannabis Use Disorders
Addresses the limited pharmacological options for stimulant and cannabis use disorders. Highlights emerging agents and behavioural pharmacotherapy integration.
Lesson 2 • Opioid Use Disorder Pharmacotherapy
Examines methadone, buprenorphine, and naltrexone for opioid use disorder management. Covers induction protocols, regulatory requirements, and overdose prevention.
Lesson 3 • Alcohol Use Disorder Medications
Covers naltrexone, acamprosate, and disulfiram for alcohol use disorder treatment. Addresses mechanisms, patient selection, and adherence strategies for each agent.
Lesson 4 • Nicotine and Tobacco Pharmacotherapy
Reviews nicotine replacement therapy, varenicline, and bupropion for smoking cessation. Addresses combination strategies and managing withdrawal symptoms.
Lesson 5 • Neurobiology of Addiction
Explains reward circuitry, dopamine dysregulation, and neuroadaptation underlying addiction. Provides the biological framework for understanding all pharmacological addiction treatments.

Chapter 8See details

Special Populations and Complex Cases

Lesson 1 • Paediatric Psychopharmacology
Covers developmental pharmacokinetics and evidence-based psychotropic use in children and adolescents. Addresses regulatory approval status and off-label prescribing considerations.
Lesson 2 • Psychotropics in Pregnancy and Lactation
Addresses fetal risk, neonatal adaptation syndrome, and drug transfer in breast milk. Prepares students to make evidence-based risk-benefit decisions for perinatal patients.
Lesson 3 • Pharmacogenomics in Psychopharmacology
Introduces genetic variation in CYP enzymes and drug transporters affecting psychotropic response. Prepares students to interpret pharmacogenomic testing and apply results clinically.
Lesson 4 • Geriatric Psychopharmacology
Examines age-related pharmacokinetic changes and polypharmacy risks in older adults. Builds skills for safe psychotropic prescribing in cognitively and medically vulnerable patients.
Lesson 5 • Medically Complex Patients
Covers psychotropic use in patients with hepatic, renal, cardiac, and neurological comorbidities. Develops dose adjustment and drug interaction management skills for complex cases.

Certification

Your valid completion certificate

This course is for you:

Psychiatric nurses seeking deeper pharmacological grounding for clinical practice.
Primary care physicians managing mental health patients without specialist backup.
Pharmacy students wanting to connect drug mechanisms to real psychiatric outcomes.
Social workers who counsel patients on psychiatric medications and their effects.
Medical residents rotating through psychiatry and needing rapid, structured knowledge.
Nurse practitioners expanding their scope into behavioural health prescribing roles.

What our students say

Your lessons are perfect. I purchased the one-year package and finally have the opportunity to follow various topics of my interest without needing to change platforms... I thank you for everything you do, I've already recommended you to other people...